De-Risk Your Complex Biologic with Developability & Manufacturability Assessments

Abzena’s integrated approach to developability assessment ensures that your biologic or bioconjugate is not only viable but optimized for success. By continually refining our selection criteria and asking the right questions early, we de-risk projects and move closer to developing ideal drugs. Our stage-appropriate development solutions are designed to meet your specific needs: -Early Stage: A rapid multi-parametric assessment of multiple variants allowing candidate triaging. -Later Stage: A more extensive biophysical assessment of a small number of variants, with a focus on aggregation, thermal stability and forced degradation studies. -Biological and Functional Assessment: In-depth evaluation of function and MoA. -Immunogenicity and Safety: Critical assessments to ensure patient safety and minimize immunogenic risk